T en years ago, the prevalence of diagnosed dementia in the California Medicaid and Georgia Medicaid populations exceeded 4%. 1, 2 To our knowledge, current estimates of diagnosed dementia for the Medicaid population have not been published but are likely to be much higher, in part because of greater attention to screening and evaluation for dementia. 3, 4 Current prevalence estimates of diagnosed dementia among Medicaid recipients are important to Medicaid programs for a number of reasons. 5, 6 Medicaid spending has recently seen a sharp increase, which has often placed Medicaid at the center of governmental budget discussions, at both federal and state levels. 7 In 1995, the annual excess spending by California Medicaid for patients with dementia was estimated at approximately $200 million, with most of those costs attributed to higher rates of institutionalization. 1 Persons with dementia are at 5 times the risk of institutionalization as those without dementia, and nearly half of the costs of nursing-home care are borne by state governments through Medicaid programs. 8, 9 Administrative claims data are a widely used costeffective resource for epidemiologic and health services research including estimating prevalence of diagnosed disease in specific populations. 1, 2, 4 However, administrative claims-based analyses of conditions such as dementia depend on many factors including reimbursement policies and the variable nature of diagnostic coding. To date, claims-based studies of prevalence of diagnosed dementia have used a wide variety of diagnosis codes, with limited consensus or specificity testing. For example, using the International Classification of Diseases (ICDs), 9th revision, Clinical Modification, studies of dementia have included codes for unspecified psychotic conditions 1,2,10-14 and senility, 1,2,10,13,15 though these terms themselves do not denote dementia.
Other patient selection factors, such as the interval of data examined, age threshold for inclusion, and number of occurrences of dementia-related claims for inclusion, may substantially alter prevalence estimates. These important factors also have varied across studies. 1, 2, [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] It is important to understand the effect of using various criteria on estimates, because the allocation of public resources for the care of persons with dementia depends on accurate estimates of prevalence.
The objectives of this study were to estimate the prevalence of diagnosed dementia among Indiana Medicaid beneficiaries in 2004 and to describe the dependency of the estimates upon specific patient selection criteria used in previous studies. We hypothesized that prevalence of diagnosed dementia would be significantly higher than seen in other Medicaid studies from a decade ago, and that factors such as increasing age threshold, increasing the number of diagnosis codes used to determine dementia, and lengthening the time interval of claims data examined to detect a diagnosis of dementia would increase the estimated prevalence of diagnosed dementia significantly.
METHODS

Research Design and Data Sources
The study was conducted with Medicaid eligibility and claims data maintained by the Indiana Family and Social Services Administration. The data files contain a unique, encrypted identifier that permits Indiana Medicaid recipients to be tracked over time. Detailed data for all claims with a date of service between July 1, 2002 and December 31, 2004 were extracted for all persons who were Medicaid eligible for at least 1 month in 2004. Data elements extracted from the eligibility files and the claim files included details on beneficiaries' age, sex, race, eligibility category, outpatient service use, institutional service (hospital and nursing home) use, and other medical service use. Outpatient and institutional service claims contained dates of service, the primary diagnosis, up to 3 secondary diagnoses (ICD codes), and the Indiana Medicaid paid amounts.
Minimum Data Set (MDS) data also was extracted for beneficiaries who resided in nursing homes any time in 2004 to determine whether each individual was designated as having dementia. That information from the MDS was used to assess specificity and sensitivity of the dementia patient selection criteria. The study was approved by the Institutional Review Board of Purdue University.
Identification of Patients With Dementia
Review of Dementia-related ICD Codes Used in Previous Studies
A literature search was conducted using MEDLINE and International Pharmaceutical Abstracts searches (1966 to present) to identify studies that had used medical claims data and ICD codes to identify patients with dementia. A keyword search was conducted using a combination of the terms ''dementia'' and either ''claims'' or ''administrative data.'' Over 140 articles were retrieved.
For the current analysis, articles that had used ICD codes to identify ''dementia patients'' or ''Alzheimer disease and related dementia patients'' from medical claims were reviewed. Studies that focused on only one specific type of dementia were excluded from the analysis. A total of 11 studies were identified that had used ICD codes to identify patients with Alzheimer disease or related dementias from medical claims.
1,2,10-18 A list of dementia-related ICD codes used in the 11 studies is provided in Table 1 . There was substantial variation in the ICD codes used across studies. None of the studies used all of the 47 ICD codes listed to identify patients with dementia. The list of all 47 ICD codes was termed the ''collective ICD set'' for the purpose of this manuscript.
Expert Panel Survey
To assess perceived specificity among clinicians of each of the ICD codes in the collective ICD set for identifying patients with dementia, we surveyed an expert panel of health professionals in Indiana with experience evaluating or treating patients with dementia. The panel, which included 3 geriatricians, a neurologist, a psychiatrist, and a neuropsychologist, rated on a 4-point scale (1 = ''Rarely,'' 2 = ''Occasionally,'' 3 = ''Frequently,'' 4 = ''Almost Always'') how often dementia occurs with each diagnosis. We specified a priori that to qualify as a specific diagnosis, at least 5 of the 6 professionals had to provide a rating of ''Almost Always'' or ''Frequently.'' This general threshold, on the basis of the content validity literature, has been validated and is widely used in expert panel surveys. 21 The ICD codes that met the a priori criteria as being perceived specific for dementia on the basis of at least 5 of the 6 experts saying ''Almost Always'' or ''Frequently,'' are highlighted in bold font and have an asterisk beside them in the ''Expert Panel'' column of Table 1 . Twenty-six of the ICD codes were indicated by the expert panel as being specific for identifying patients with dementia and were termed the ''expert panel ICD set'' for the purpose of this manuscript.
Evaluation of the Effect of Patient Selection Criteria on Prevalence Estimates
We assessed whether prevalence estimates of diagnosed dementia among Indiana Medicaid beneficiaries differed depending on each of the following factors: (1) 
Specificity and Sensitivity of the Dementia Patient Selection Criteria
To assess specificity and sensitivity of the combination of patient selection criteria used in the current study for identifying patients with dementia, dementia classifications on the basis of the selection criteria were compared with MDS information on whether individuals were designated as having dementia for individuals who Senile and presenile organic psychotic conditions 290
Dementia in conditions classified elsewhere with behavioral disturbance
*ICD codes that were rated as specific for dementia diagnosis by the expert panel are in bold and have an asterisk beside them. wSuperscript numbers are the corresponding references for each study as listed in the reference section in this paper.
were in nursing homes any time in 2004. Previous studies have demonstrated good reliability of MDS reported diagnoses. 22 For this analysis of comparison with the MDS information, the use of the expert panel ICD code and examination of up to 30 months of data to detect dementia diagnosis were kept constant in the dementia patient selection criteria. For the selection criteria involving number of occurrences of dementia-related claims, most of the published studies using medical claims data required only one occurrence of a dementiarelated claim as a criterion to identify patients with dementia.
1,2,10-12, 16 One Medicare study required at least 2 occurrences of dementia-related claims suggesting that this method would increase specificity of identification of dementia patients. 20 However, the use of 2 or more dementia-related claims has a potential to result in exclusion of patients with a single claim because of a new, though perhaps valid diagnosis. 20 As a result, specificity, sensitivity, accuracy, negative predictive value, and positive predictive value were compared using 1 or more dementia-related claims and using 2 or more dementia-related claims as criteria. Comparisons also were made among individuals age 40 years or older and individuals age 60 years or older.
Prevalence Estimates of Diagnosed Dementia in Indiana Medicaid Population
Age-specific prevalence estimates of diagnosed dementia were calculated for individuals of age 40 years old to 90 years old in age increments of 5 years and for various age thresholds including 40 years or older, 50 years or older, 60 years or older, 70 years or older, 80 years or older, and 90 years or older.
Comparison of Prevalence Estimates With Previous Studies in the Medicaid Population
To compare differences in estimates of prevalence of diagnosed dementia over 10 years, estimates also were calculated using dementia patient selection criteria from previous studies of the Georgia Medicaid 2 and the California Medicaid populations. 1 We constructed 95% confidence intervals to assess differences in sex, race, Medicaid eligibility categories, and proportions that were dual Medicare and Medicaid eligible in the diagnosed dementia populations between Indiana and the other 2 states. 23 
RESULTS
Sample Characteristics
Among all 2004 Indiana Medicaid beneficiaries, 17% were 40 years or older, 12% were 50 years or older, and 9% were 60 years or older. Among beneficiaries that were 40 years or older, approximately 66% were women, 76% were white, and 62% were dual Medicare and Medicaid eligible. Approximately, 24% of Indiana Medicaid beneficiaries 40 years or older received nursing-facility care some time in 2004.
Evaluation of the Effect of Patient Selection Criteria on Estimates of Prevalence of Diagnosed Dementia
Age-specific prevalence estimates of diagnosed dementia using different combinations of ICD code sets, number of occurrences of dementia-related claims, and months of data used are shown in Table 2 . The Table shows the prevalence of diagnosed dementia among individuals 40 years or older and individuals 60 years or older, beginning from the most restrictive patient selection criteria using the expert panel ICD set, 2 or more occurrences of dementia-related claims, and up to 12 months of data (baseline). The estimates varied substantially by combination of criteria used. The prevalence of diagnosed dementia among Indiana Medicaid beneficiaries 40 years or older was 15.3% using the collective ICD set, occurrence of 1 or more dementia-related claims, and up to 30 months of data. However, the estimate in the same age group dropped to 7.7% using the expert panel ICD set, occurrence of 2 or more dementia-related claims, and up to 12 months of data. The impact of patient selection criteria on dementia prevalence estimates was similar among Indiana Medicaid beneficiaries 60 years or older, ranging from 14.5% to 26.6%. When using the baseline criteria but changing the interval of data examined from up to 12 months to up to 30 months estimates increased from 7.7% to 9.5% among 40 years or older and 14.5% to 17.9% among 60 years or older and when changing the ICD set used from the expert panel ICD set to the collective ICD set, estimates increased from 7.7% to 10.1% among 40 years or older and from 14.5% to 18.5% among 60 years or older (Table 2 ). Table 3 compares dementia classification on the basis of the selected combination of patient selection criteria for this study with MDS data on dementia diagnosis. For both age strata examined, the patient selection criteria was varied to assess specificity and sensitivity when using 1 or more dementia-related claims as compared with using 2 or more dementia-related claims to identify patients. Dementia classification on the basis of 1 or more dementia-related claims had higher sensitivity, accuracy, and negative predictive value as compared with dementia classification on the basis of 2 or more dementia-related claims. Although dementia classification on the basis of 2 or more dementia-related claims had slightly better specificity (88% vs. 85% among 40 y or older and 87% vs. 84% among 60 y or older), the loss in sensitivity with that approach compared with the use of 1 or more dementia-related claims was sizeable (63% vs. 69% among both the 40 y or older and the 60 y or older). Overall accuracy was also higher using the criterion of 1 or more dementia-based claims rather than 2 or more claims, that is, 77% vs. 76% for a sample including persons 40 years or older and 76% versus 75% for a 
Specificity and Sensitivity of the Dementia Patient Selection Criteria
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Age-specific Prevalence Estimates of Diagnosed Dementia in Indiana
Using the expert panel ICD set, occurrence of 1 or more dementia-related claims and up to 30 months of data, the age-specific prevalence of diagnosed dementia among Indiana Medicaid beneficiaries in 2004 was estimated ( Table 4 ). The estimated prevalence of diagnosed dementia in Indiana Medicaid were 10.9% for individuals aged 40 years or older, 15.2% for individuals 50 years or older, and 20.3% for individuals 60 years or older. The estimate of prevalence of diagnosed dementia in the age group 40 to 44 years was 0.8%. Estimates of prevalence of diagnosed dementia increased by a factor of 1.5 to 2 with 5-year increments in age from 60 to 64 years to 80 to 84 years. The estimated prevalence of diagnosed dementia was 38.2% among Indiana Medicaid beneficiaries 90 years or older. 
Characteristics of Patients With Dementia in Indiana
Comparison of Prevalence Estimates With Previous Studies in the Medicaid Population
To investigate whether the higher prevalence of diagnosed dementia in this study as compared with previous estimates was due to differences in selection criteria used, estimates in Indiana were calculated based on selection criteria used in a study of the 1994 prevalence of diagnosed dementia in the Georgia Medicaid population 2 and on the basis of the criteria used in a study of the 1995 prevalence of diagnosed dementia in the California Medicaid population 1 (Table 5) . Using the Georgia Medicaid study criteria, which included use of selected ICD codes (column B of Table 1 ), 1 or more occurrence of dementia-related claims, and up to 12 months of data, the prevalence of diagnosed dementia in Indiana was 13.1% among beneficiaries 50 years or older as compared with 4.4% reported for that age group in the 1994 Georgia Medicaid study. 2 Using the California Medicaid study criteria that included use of selected ICD codes (column A of Table 1 ), for 1 or more occurrences of dementia-related claims, from up to 12 months of data, the prevalence of diagnosed dementia in Indiana was 17.3% among beneficiaries 60 years or older as compared with 4.1% reported for that age group in the 1995 California Medicaid study. 1 The Georgia Medicaid diagnosed dementia population and the California Medicaid diagnosed dementia population were compared with the Indiana Medicaid diagnosed dementia population on sex, race, Medicaid eligibility category, and proportion that were dual Medicare and Medicaid eligible ( Table 5) . As indicated by the nonoverlapping 95% confidence intervals for each variable, the diagnosed dementia populations from Indiana and the 2 states differed significantly. The 2004 Indiana Medicaid dementia population had higher proportions of whites and individuals eligible in the aged category whereas there were lower proportions of blacks, individuals eligible in the blind or disabled category and individuals that were dual 
DISCUSSION
In 2004, the prevalence of diagnosed dementia among Indiana Medicaid beneficiaries was estimated at 15.2% among individuals age 50 years or older and 20.3% among individuals age 60 years or older. This is a marked difference from studies of the 1994 Georgia Medicaid population 2 and 1995 California Medicaid population (3.5 times to 5 times higher). 1 The current diagnosed dementia prevalence estimates using the same selection criteria as the Georgia Medicaid study 2 and the California Medicaid study 1 still remained at 3 to 4 times higher than the 1994 and 1995 estimates reported in those studies.
A similar difference over time in estimated prevalence of diagnosed Alzheimer disease was identified in a 9-year longitudinal study of Medicare beneficiaries by Taylor et al. 15 The authors found a 2.5-fold increase in cases identified with Alzheimer disease in 1999, when compared with 1991. Multiple factors may be responsible for the higher estimates of diagnosed dementia found in the present study. The widespread availability of pharmacologic agents for treatment of dementia since 1994 may have resulted in increased screening and evaluation of dementia. Coverage of dementia in the public press and media also may have prompted more attention to diagnosis and subsequent coding of dementia. Some Centers for Medicare and Medicaid Services (CMS) policies such as Program Memorandum AB01-135 published in 2001 that discouraged Medicare contractors from automatic denial of services for patients with dementia based solely on ICD-9 codes and encouraged specific coding for dementia also may have contributed to increases in coding and subsequent increases in the observed diagnosed dementia prevalence estimates. 24 Selection of claims-based criteria for identifying patients with dementia affected prevalence estimates by nearly 100%. Prevalence estimates of diagnosed dementia varied greatly across age strata. Each of the selection criteria, including ICD codes used, the age threshold used, minimum number of dementia-related claims used, and months of data examined, had similar impact on prevalence estimates. The estimates of diagnosed dementia for individuals 40 years or older varied from 7.7% to 15.3%, whereas the estimates for individuals 60 years or older varied from 14.5% to 26.6%, depending on the selection criterion used.
Review of the literature on dementia-related ICD codes used in previous studies showed wide variation in ICD codes used across studies. This makes meaningful comparison of findings across studies difficult or impossible. Some studies have used ICD codes for unspecified psychotic conditions 1,2,10-14 and senility, 1,2,10,13,15 to identify patients with dementia, though these terms themselves do not denote dementia. Use of nonspecific ICD codes like 290 may have been appropriate in earlier studies due to lower incentives for coding with 4-digit ICD codes than currently exist. The current study generated a list of ICD codes, the ''expert panel ICD set'' (a subset of the collective ICD set obtained from review of previous studies) by surveying a panel of health professionals with experience evaluating or treating patients with dementia. The expert panel ICD set contained a list of ICD codes that clinicians perceived as specific for identifying patients with dementia. The expert panel ICD set derived in this study may be useful for other investigators as well in identifying patients with dementia from administrative claims data.
The patient selection criteria used in this study which included use of the expert panel ICD set, occurrence of 1 or more dementia-related claims and up to 30 months of data, had good specificity (85%), sensitivity (69%), and accuracy (77%) when compared with MDS data. These levels of agreement are comparable to previous published studies in other therapy areas that have assessed agreement of case ascertainment techniques on the basis of the medical claims with medical records. 25 Estimates of prevalence of diagnosed dementia are important and have implications for resource allocation, especially within Medicaid. Close to one-half of nursinghome care expenditures are borne by the Medicaid program. 9 Nursing-home expenditures were estimated at $115.4 billion in 2004. 26 Previous studies have indicated that the prevalence of dementia among nursing-home residents at admission is approximately 50%. 27 The study has several limitations. Claims data are recorded for reimbursement and administration purposes and are not likely to capture perfectly occurrences of a disease. However, identification of individuals with diagnosed disease from administrative claims data using ICD codes is accepted and widely used in research. Our comparison of dementia classification from claims with MDS reported diagnoses provides greater confidence in the estimates. Comparison between dementia classifications on the basis of the medical claims with MDS reported diagnoses was possible only in a subset of Medicaid beneficiaries that resided in nursing homes at some time in 2004. Although limited to nursing home patients, the analysis allowed for comparison with MDS reported diagnosis which has been shown to have good reliability. 22 Data were not available to permit assessment of the patient selection criteria for specificity and sensitivity among the subset of the sample that had no nursing home use in 2004.
All analyses in the study were conducted on Medicaid beneficiaries that were eligible for at least Some of the differences in prevalence estimates of diagnosed dementia across the states examined may be explained by differences in the characteristics of the Medicaid populations or differences in the general populations in the states. Comparing 2003 Medicaid data for each state, Georgia had a slightly higher proportion of Medicaid beneficiaries 65 years or older (10%) as compared with Indiana (8.6%) or California (8.7%). 28 However, on the basis of the 2000 census data, Indiana had a higher proportion of individuals of age 65 to 74 years (6.5%), 75 to 84 years (4.4%), and 85 years or older (1.5%) as compared with Georgia (65 to 74 y-5.3%, 75 to 84 y-3.2%, 85 y or older-1.1%) or California (65 to 74 y-5.6%, 75 to 84 y-3.8%, 85 y or older-1.0%), possibly explaining some of the higher estimated prevalence of diagnosed dementia observed in Indiana compared with Georgia or California. 29 The differences observed in the dementia populations across the states were consistent with the population make-up of each of the states. 30 In conclusion, the combination of the patient selection criteria used in this study that included the expert panel ICD set, 1 or more dementia-related claims, and use of up to 30 months of data, provides a balance between sensitivity and specificity in identifying patients with dementia from medical claims. Using those criteria, the estimate of prevalence of diagnosed dementia in the Indiana Medicaid population among individuals 60 years or older was 20.3% in 2004. The estimated prevalence of diagnosed dementia among Medicaid beneficiaries is more than 3 times estimates from a decade ago for other Medicaid populations. Although a number of factors including aging of the population, changes in ICD coding, and better diagnosis of dementia may be responsible for the increase, the estimates show the need for increased allocation of resources for this disease.
